Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Mecamylamine-precipitated nicotine withdrawal syndrome and its prevention with baclofen: an autoradiographic study of α4β2 nicotinic acetylcholine receptors in mice.

Varani AP, Antonelli MC, Balerio GN.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:217-25. doi: 10.1016/j.pnpbp.2013.02.016. Epub 2013 Mar 14.

PMID:
23500668
2.

Baclofen prevented the changes in c-Fos and brain-derived neutrophic factor expressions during mecamylamine-precipitated nicotine withdrawal in mice.

Varani AP, Moutinho Machado L, Balerio GN.

Synapse. 2014 Nov;68(11):508-17. doi: 10.1002/syn.21763. Epub 2014 Aug 21.

PMID:
25042794
3.

Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal.

Varani AP, Moutinho LM, Calvo M, Balerio GN.

Drug Alcohol Depend. 2011 Dec 1;119(1-2):e5-12. doi: 10.1016/j.drugalcdep.2011.05.017. Epub 2011 Jul 5.

PMID:
21733642
4.

Lack of GABAB receptors modifies behavioural and biochemical alterations induced by precipitated nicotine withdrawal.

Varani AP, Pedrón VT, Machado LM, Antonelli MC, Bettler B, Balerio GN.

Neuropharmacology. 2015 Mar;90:90-101. doi: 10.1016/j.neuropharm.2014.11.013. Epub 2014 Dec 3.

PMID:
25479464
5.
6.
7.

Involvement of GABAB receptors in biochemical alterations induced by anxiety-related responses to nicotine in mice: genetic and pharmacological approaches.

Varani AP, Pedrón VT, Bettler B, Balerio GN.

Neuropharmacology. 2014 Jun;81:31-41. doi: 10.1016/j.neuropharm.2014.01.030. Epub 2014 Jan 30.

PMID:
24486711
8.

Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice.

Pedrón VT, Varani AP, Balerio GN.

Synapse. 2016 May;70(5):187-97. doi: 10.1002/syn.21886. Epub 2016 Feb 16.

PMID:
26789010
9.

Sexually diergic hypothalamic-pituitary-adrenal (HPA) responses to single-dose nicotine, continuous nicotine infusion, and nicotine withdrawal by mecamylamine in rats.

Gentile NE, Andrekanic JD, Karwoski TE, Czambel RK, Rubin RT, Rhodes ME.

Brain Res Bull. 2011 May 30;85(3-4):145-52. doi: 10.1016/j.brainresbull.2011.03.001. Epub 2011 Mar 17.

10.

Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens.

Schmidt BL, Tambeli CH, Gear RW, Levine JD.

Neuroscience. 2001;106(1):129-36.

PMID:
11564423
11.

[3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study.

Perry DC, Kellar KJ.

J Pharmacol Exp Ther. 1995 Nov;275(2):1030-4.

PMID:
7473129
12.

Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice.

Ponzoni L, Moretti M, Sala M, Fasoli F, Mucchietto V, Lucini V, Cannazza G, Gallesi G, Castellana CN, Clementi F, Zoli M, Gotti C, Braida D.

Eur Neuropsychopharmacol. 2015 Oct;25(10):1775-86. doi: 10.1016/j.euroneuro.2015.06.010. Epub 2015 Jun 20.

PMID:
26141510
13.

Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.

Paterson NE, Markou A.

Psychopharmacology (Berl). 2004 Apr;173(1-2):64-72. Epub 2004 Jan 8.

PMID:
14712336
14.

Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors.

Ericson M, Molander A, Löf E, Engel JA, Söderpalm B.

Eur J Pharmacol. 2003 Apr 25;467(1-3):85-93.

PMID:
12706460
15.

Characterization of spontaneous and precipitated nicotine withdrawal in the mouse.

Damaj MI, Kao W, Martin BR.

J Pharmacol Exp Ther. 2003 Nov;307(2):526-34. Epub 2003 Sep 11.

17.

The role of nicotinic acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects of nicotine.

Palmatier MI, Liu X, Caggiula AR, Donny EC, Sved AF.

Neuropsychopharmacology. 2007 May;32(5):1098-108. Epub 2006 Nov 8.

18.

Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats.

Marcinkiewcz CA, Prado MM, Isaac SK, Marshall A, Rylkova D, Bruijnzeel AW.

Neuropsychopharmacology. 2009 Jun;34(7):1743-52. doi: 10.1038/npp.2008.231. Epub 2009 Jan 14.

19.

Baclofen did not modify sexually dimorphic c-Fos expression during morphine withdrawal syndrome.

Pedrón VT, Taravini IR, Induni AS, Balerio GN.

Synapse. 2013 Mar;67(3):118-26. doi: 10.1002/syn.21620. Epub 2012 Nov 28.

PMID:
23152154
20.

Supplemental Content

Support Center